Melissa Rewolinski is Director of LANNETT CO INC. Currently has a direct ownership of 93,259 shares of LCI, which is worth approximately $2,797. The most recent transaction as insider was on Sep 14, 2022, when has been sold 31,159 shares (Common Stock) at a price of $0.49 per share, resulting in proceeds of $15,268. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.3K
0% 3M change
0% 12M change
Total Value Held $2,797

Melissa Rewolinski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 14 2022
BUY
Open market or private purchase
$15,268 $0.49 p/Share
31,159 Added 25.04%
93,259 Common Stock
Sep 09 2021
SELL
Open market or private sale
$80,581 $3.18 p/Share
25,340 Reduced 28.98%
62,100 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
-
56,819 Added 39.39%
87,440 Common Stock
Sep 03 2020
SELL
Open market or private sale
$75,278 $5.32 p/Share
14,150 Reduced 31.61%
30,621 Common Stock

Also insider at

ABUS
Arbutus Biopharma Corp Healthcare
MR

Melissa Rewolinski

Director
Philadelphia, PA

Track Institutional and Insider Activities on LCI

Follow LANNETT CO INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCI shares.

Notify only if

Insider Trading

Get notified when an Lannett CO Inc insider buys or sells LCI shares.

Notify only if

News

Receive news related to LANNETT CO INC

Track Activities on LCI